Claims for Patent: 11,332,451
✉ Email this page to a colleague
Summary for Patent: 11,332,451
Title: | RIP1 inhibitory compounds and methods for making and using the same |
Abstract: | Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising such inhibitory compounds. The disclosed compounds, pharmaceutical compositions, and/or combinations may be used to treat or prevent a kinase-associated disease or condition, particularly a RIP1-associated disease or condition. |
Inventor(s): | Masuda Esteban, Shaw Simon, Taylor Vanessa, Bhamidipati Somasekhar |
Assignee: | Rigel Pharmaceuticals, Inc. |
Application Number: | US17023127 |
Patent Claims: |
Details for Patent 11,332,451
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | January 10, 1978 | ⤷ Subscribe | 2040-09-16 |
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | November 26, 1997 | ⤷ Subscribe | 2040-09-16 |
Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | February 19, 2002 | ⤷ Subscribe | 2040-09-16 |
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | August 24, 1998 | ⤷ Subscribe | 2040-09-16 |
Swedish Orphan Biovitrum Ab (publ) | KINERET | anakinra | Injection | 103950 | November 14, 2001 | ⤷ Subscribe | 2040-09-16 |
Novartis Pharmaceuticals Corporation | COSENTYX | secukinumab | Injection | 125504 | January 21, 2015 | ⤷ Subscribe | 2040-09-16 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.